Author:
Solomon Zachary J.,Mirabal Jorge Rivera,Mazur Daniel J.,Kohn Taylor P.,Lipshultz Larry I.,Pastuszak Alexander W.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Urology Care Foundation
Subject
Urology,Obstetrics and Gynaecology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health
Reference55 articles.
1. Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140;Miller;ACS Med Chem Lett,2011
2. Study design and rationale for the phase 3 clinical development program of enobosarm, a selective androgen receptor modulator, for the prevention and treatment of muscle wasting in cancer patients (POWER Trials);Crawford;Curr Oncol Rep,2016
3. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: Results of a double-blind, placebo-controlled phase II trial;Dalton;J Cachexia Sarcopenia Muscle,2011
4. Structure-based approach to identify 5-[4-hydroxyphenyl]pyrrole-2-carbonitrile derivatives as potent and tissue selective androgen receptor modulators;Unwalla;J Med Chem,2017
5. Is testosterone a friend or a foe of the prostate?;Jannini;J Sex Med,2011
Cited by
128 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献